OBJECTIVE: The present meta-analysis aimed to compare the short-term safety and efficacy of drug-eluting stents and coronary artery bypass graft surgery for @entity1 with @entity453 . METHODS: Fourteen relevant studies were identified from 5 electronic databases. End points included mortality, @entity64 , @entity583 , repeat revascularization, and major adverse cardiac and cerebrovascular events. RESULTS: Results indicate that all-cause mortality was similar between drug-eluting stents and coronary artery bypass grafting at 30 days and at follow-up beyond 1 year. Likewise, the incidence of @entity583 was similar between drug-eluting stents and coronary artery bypass grafting at 12 months and at follow-up beyond 1 year. However, drug-eluting stents were associated with a lower incidence of all-cause mortality at 12 months and a higher incidence of @entity583 at 30 days compared with coronary artery bypass grafting. @entity734 were consistently associated with a higher incidence of repeat revascularization, whereas coronary artery bypass grafting had a higher incidence of @entity64 . The incidence of major adverse cardiac and cerebrovascular events was similar between the 2 groups at 30 days but higher for drug-eluting stents at 12 months and beyond. CONCLUSIONS: @entity1 treated by drug-eluting stents in randomized controlled trials and observational studies in the current literature are often a preselected subgroup with less complex lesions compared with the overall target population. Results drawn from these studies should be viewed with caution. Coronary artery bypass grafting is associated with a lower incidence of major adverse cardiac and cerebrovascular events at 1 year and beyond, and thus should be regarded as the standard of treatment. However, drug-eluting stents may have a role for selected @entity1 with percutaneously amenable left main disease who are poor surgical candidates.

@entity734 versus coronary artery bypass graft surgery in XXXX : a meta-analysis of early outcomes from randomized and nonrandomized studies.

@entity1 :: ('9606', 'Species') :: ['Patients', 'patients'] @entity64 :: ('MESH:D020521', 'Disease') :: ['stroke'] @entity583 :: ('MESH:D009203', 'Disease') :: ['myocardial infarction'] @entity453 :: ('MESH:D003324', 'Disease') :: ['left main coronary artery disease'] @entity734 :: ('MESH:D019966', 'Disease') :: ['Drug-eluting stents']
@entity453 :: (MESH:D003324,Disease) :: ['left main coronary artery disease']
